Regulatory6 min read
GLP-1 Compounding Crackdown: Your Options Now
FDA sent 30 warning letters to telehealth GLP-1 compounders. Here's what's still legal, what changed, and where to source semaglutide and tirzepatide now.
Peptide Regulatory News
FDA actions, public comments, compounding rules.
Daily Peptide News
New articles delivered to your inbox every morning. Free.
State-by-state legal guides
Are peptides legal in your state? Updated for 2026.
Regulatory News
Regulatory10 min read
Why Your Pharmacy Won't Compound CJC-1295 (But Another Will)
503A vs 503B, Category 1 vs 2, and why some pharmacies prescribe peptides others refuse. The regulatory map no one explains clearly.
Regulatory7 min read
12 Peptides Off FDA Category 2: April 22
FDA pulled 12 peptides from the Category 2 restricted list April 15 -- effective April 22. Includes GHK-Cu and Melanotan II. Full list and what it changes.
Regulatory6 min read
BPC-157 Public Comment Deadline: July 9
FDA opened a public docket today on BPC-157, TB-500, KPV, and MOTS-c. Comments before July 9 reach the committee. Here's how to submit one.
Regulatory4 min read
FDA Panel to Review 7 Peptides in July
FDA advisory committee meets July 23-24 to decide on BPC-157, TB-500, KPV, and 4 more peptides. What it means for buyers and compounding access.